News

Walking is a fundamental activity for maintaining health. While numerous studies have assessed how much people with chronic ...
and lifestyle changes Chronic obstructive pulmonary disease, commonly referred to as COPD, is a group of progressive lung diseases. An estimated 32 million people in the United States have COPD.
Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.
Chronic obstructive pulmonary disease (COPD) affects millions of Americans, with new data from the National Center for Health Statistics showing the condition becomes increasingly common as people age ...
People who lost weight in midlife were less likely to experience heart attacks, strokes, cancer, asthma or chronic ...
(Reuters) -Regeneron shares fell nearly 18% on Friday after its experimental drug for patients with a type of lung condition ...
Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.
Sanofi’s plans to submit itepekimab to regulators for approval this year have been thrown into doubt after the ...
Paris: Sanofi has announced that the AERIFY-1 phase 3 study evaluating itepekimab in former smokers with inadequately ...
The AERIFY program includes two additional ongoing trials: AERIFY-3, a Phase 2 mechanistic study assessing the impact of itepekimab on airway inflammation in patients with COPD, and AERIFY-4, a Phase ...